Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 1Recurrence 1Ovarian Neoplasms 1Melanoma 1Locally Advanced Colorectal Cancer 1Gastric Adenocarcinoma 1Colorectal Cancer Metastatic 1

Interventions

sintilimab 1Tyrosine Kinase Inhibitors 1SHR-1701 1N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1Immune Checkpoint Inhibitors 1HMPL-013 1Decitabine 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Colorectal Cancer Metastatic × SHR-1701 × Clear all
NCT06679673 2024-11-07

SHR-1701 Combined with SHR2554 and BP102 for MCRC

Fudan University

Phase 2 Not yet recruiting
20 enrolled
Gastrointestinal

Colorectal Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡